Joshua Ordway, MD
Family Medicine · Franklin, OHNPI 1285952143
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $135,581 of the $165,537 with a category attached, or 81.9%. AbbVie accounts for 94.3% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $65,881, more than ten times the $1,864 reported in 2019. Among family medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,363 payments — averaging $121.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$156K
- AstraZeneca$2K
- Johnson & Johnson$2K
- Novo Nordisk$858
- Corium, LLC$793
- Amarin Pharma, Inc.$550
- plus $4K from 28 others
Across 75 payments — averaging $1790.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$70K
- Sagent Pharmaceuticals$36K
- Novo Nordisk AS$28K
What the payments were for
- Consulting fees$7,1254%
- Speaking & faculty fees$135,58182%
- Travel & lodging$5,5603%
- Food & beverage$17,24810%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 726 | $156,098 |
| AstraZeneca | 49 | $1,789 |
| Johnson & Johnson | 119 | $1,620 |
| Novo Nordisk | 82 | $858 |
| Corium, LLC | 65 | $793 |
| Amarin Pharma, Inc. | 63 | $550 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $487 |
| Nestle Healthcare Nutrition Inc. | 43 | $466 |
| Teva Pharmaceuticals USA, Inc. | 34 | $332 |
| Supernus Pharmaceuticals, Inc. | 20 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $282 |
| Sanofi-aventis U.S. LLC | 11 | $225 |
| Merck | 14 | $215 |
| Amgen | 6 | $205 |
| Boehringer Ingelheim | 10 | $172 |
| Pfizer | 14 | $143 |
| Novartis | 7 | $137 |
| Acerus Pharmaceuticals Corporation | 19 | $133 |
| Lilly USA, LLC | 8 | $126 |
| Dynavax Technologies Corporation | 1 | $81 |
| Aimmune Therapeutics, Inc. | 4 | $58 |
| Astellas Pharma US Inc | 2 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $53 |
| Bayer | 3 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $46 |
| Antares Pharma, Inc. | 3 | $44 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Boston Scientific | 2 | $34 |
| Almatica Pharma LLC | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Exact Sciences | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $12 |
| Dexcom, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$165,537 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 99 | $145,158 |
| MounjaroTirzepatide | 32 | $53,940 |
| LinzessLinaclotide | 36 | $44,928 |
| XareltoRivaroxaban | 30 | $43,050 |
| RybelsusSemaglutide | 25 | $40,200 |
| FarxigaDapagliflozin Propanediol | 38 | $39,766 |
| VraylarCariprazine Hcl | 20 | $36,737 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 18 | $29,426 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $23,499 |
| Xigduo XrDapaglifloz Propaned/Metformin | 15 | $23,304 |
| JardianceEmpagliflozin | 12 | $19,752 |
| TrulicityDulaglutide | 13 | $17,741 |
| UbrelvyUbrogepant | 14 | $17,605 |
| EliquisApixaban | 17 | $14,405 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $10,264 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $858 | $185,358124 claims |
| AbbVieLinzess, Vraylar, Ubrelvy, Synthroid | $156,098 | $101,281114 claims |
| Lilly USA, LLCMounjaro, Trulicity | $126 | $71,68245 claims |
| AstraZenecaFarxiga, Symbicort | $1,789 | $50,03056 claims |
| Johnson & JohnsonXarelto | $1,620 | $43,05030 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $225 | $29,42618 claims |
| Boehringer IngelheimJardiance | $172 | $19,75212 claims |
| PfizerEliquis | $143 | $14,40517 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $14 | $1,941266 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Franklin
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.